peptide elongation factor 2 has been researched along with ketamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charney, DS; Henter, ID; Luckenbaugh, DA; Niciu, MJ; Zarate, CA | 1 |
| Gideons, ES; Kavalali, ET; Monteggia, LM | 1 |
| Cubała, WJ; Gałuszko-Węgielnik, M; Górska, N; Jakuszkowiak-Wojten, K; Szarmach, J; Szałach, ŁP; Słupski, J; Wiglusz, MS; Wilkowska, A; Włodarczyk, A | 1 |
1 review(s) available for peptide elongation factor 2 and ketamine
| Article | Year |
|---|---|
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
Topics: Antidepressive Agents; Depression; Excitatory Amino Acid Antagonists; Glycogen Synthase Kinase 3; Humans; Ketamine; Peptide Elongation Factor 2; Randomized Controlled Trials as Topic; TOR Serine-Threonine Kinases | 2014 |
2 other study(ies) available for peptide elongation factor 2 and ketamine
| Article | Year |
|---|---|
Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Blotting, Western; Brain-Derived Neurotrophic Factor; Cells, Cultured; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Humans; Ketamine; Magnesium; Male; Memantine; Mice; Mice, Inbred C57BL; Motor Activity; Neurons; Patch-Clamp Techniques; Peptide Elongation Factor 2; Phosphorylation; Receptors, N-Methyl-D-Aspartate; Time Factors | 2014 |
Magnesium and ketamine in the treatment of depression.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Depressive Disorder; Humans; Ketamine; Magnesium; Peptide Elongation Factor 2; Receptors, N-Methyl-D-Aspartate | 2019 |